{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T09:39:24Z","timestamp":1771493964214,"version":"3.50.1"},"reference-count":62,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.neuint.2009.11.008","type":"journal-article","created":{"date-parts":[[2009,11,19]],"date-time":"2009-11-19T19:00:19Z","timestamp":1258657219000},"page":"357-362","source":"Crossref","is-referenced-by-count":26,"title":["l-DOPA-induced 6-hydroxydopamine production in the striata of rodents is sensitive to the degree of denervation"],"prefix":"10.1016","volume":"56","author":[{"given":"Anupom","family":"Borah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kochupurackal P.","family":"Mohanakumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuint.2009.11.008_bib1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00213-007-0929-2","article-title":"Neurobehavioral protection by single dose l-deprenyl against MPTP-induced parkinsonism in common marmosets","volume":"195","author":"Ando","year":"2008","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuint.2009.11.008_bib2","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/BF00978370","article-title":"The determination of hydroxydopamines and other trace amines in the urine of parkinsonian patients and normal controls","volume":"18","author":"Andrew","year":"1993","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuint.2009.11.008_bib3","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s11064-007-9473-z","article-title":"Evidence for hydroxyl radical scavenging action of nitric oxide donors in the protection against 1-methyl-4-phenylpyridinium-induced neurotoxicity in rats","volume":"33","author":"Banerjee","year":"2008","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuint.2009.11.008_bib4","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1007\/s11064-007-9299-8","article-title":"Apoptotic mode of cell death in substantia nigra following intranigral infusion of the parkinsonian neurotoxin, MPP+ in Sprague\u2013Dawley rats: cellular, molecular and ultrastructural evidences","volume":"32","author":"Banerjee","year":"2007","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuint.2009.11.008_bib5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/35072550","article-title":"Experimental models of Parkinson's disease","volume":"2","author":"Beal","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuint.2009.11.008_bib6","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s10571-007-9213-6","article-title":"Long-term l-DOPA treatment causes indiscriminate increase in dopamine levels at the cost of serotonin synthesis in discrete brain regions of rats","volume":"27","author":"Borah","year":"2007","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.neuint.2009.11.008_bib7","doi-asserted-by":"crossref","first-page":"160","DOI":"10.5214\/ans.0972.7531.2009.160406","article-title":"Long term l-DOPA treatment causes production of 6-OHDA in the mouse striatum: involvement of hydroxyl radical","volume":"16","author":"Borah","year":"2009","journal-title":"Ann. Neurosci."},{"key":"10.1016\/j.neuint.2009.11.008_bib8","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1600-079X.2009.00713.x","article-title":"Melatonin inhibits 6-hydroxydopamine production in the brain to protect against experimental parkinsonism in rodents","volume":"47","author":"Borah","year":"2009","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.neuint.2009.11.008_bib9","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1073\/pnas.80.14.4546","article-title":"A primate model of Parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"80","author":"Burns","year":"1983","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuint.2009.11.008_bib10","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/0014-4886(92)90008-E","article-title":"(\u2212) deprenyl increases activities of superoxide dismutase and catalase in striatum but not in hippocampus: the sex and age-related differences in the optimal dose in the rat","volume":"116","author":"Carrillo","year":"1992","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuint.2009.11.008_bib11","doi-asserted-by":"crossref","first-page":"S263","DOI":"10.1016\/S1353-8020(08)70014-2","article-title":"l-DOPA-induced dyskinesia: cellular mechanisms and approaches to treatment","volume":"13","author":"Cenci","year":"2007","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neuint.2009.11.008_bib12","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1523\/JNEUROSCI.3602-07.2008","article-title":"Unregulated cytosolic dopamine causes neurodegeneration associated with oxidative stress in mice","volume":"28","author":"Chen","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2009.11.008_bib13","first-page":"251","article-title":"Role of dopamine autoxidation, hydroxyl radical generation, and calcium overload in underlying mechanisms involved in MPTP-induced parkinsonism","volume":"60","author":"Chiueh","year":"1993","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.neuint.2009.11.008_bib14","first-page":"189","article-title":"Suppression of hydroxyl radical formation by MAO inhibitors: a novel possible neuroprotective mechanism in dopaminergic neurotoxicity","volume":"41","author":"Chiueh","year":"1994","journal-title":"J. Neural. Transm. Suppl."},{"key":"10.1016\/j.neuint.2009.11.008_bib15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0014-2999(84)90700-3","article-title":"Pargyline and deprenyl prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in monkeys","volume":"106","author":"Cohen","year":"1984","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuint.2009.11.008_bib16","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1749-6632.2003.tb07472.x","article-title":"Cellular models to study dopaminergic injury responses","volume":"991","author":"Collier","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuint.2009.11.008_bib17","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0021-9673(00)90882-3","article-title":"Mass fragmentography of dopamine and 6-hydroxydopamine. Application to the determination of dopamine in human brain biopsies from the caudate nucleus","volume":"99","author":"Curtius","year":"1974","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.neuint.2009.11.008_bib18","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/exnr.1993.1008","article-title":"Pre- and postsynaptic neurotoxic effects of dopamine demonstrated by intrastriatal injection","volume":"119","author":"Filloux","year":"1993","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuint.2009.11.008_bib19","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0079-6123(08)00923-0","article-title":"Parkinson's disease\u2014opportunities for novel therapeutics to reduce the problems of levodopa therapy","volume":"172","author":"Fox","year":"2008","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuint.2009.11.008_bib20","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1046\/j.1471-4159.1997.69031322.x","article-title":"Dopamine transporter is required for in vivo MPTP neurotoxicity: evidence from mice lacking the transporter","volume":"69","author":"Gainetdinov","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2009.11.008_bib21","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0026-895X(25)13535-9","article-title":"Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones","volume":"14","author":"Graham","year":"1978","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuint.2009.11.008_bib22","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1002\/ana.21573","article-title":"What causes cell death in Parkinson's disease?","volume":"64","author":"Gupta","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2009.11.008_bib23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bbr.2005.04.011","article-title":"Swim-test as a function of motor impairment in MPTP model of Parkinson's disease: a comparative study in two mouse strains","volume":"163","author":"Haobam","year":"2005","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuint.2009.11.008_bib24","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1073\/pnas.93.5.1956","article-title":"Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections","volume":"93","author":"Hastings","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuint.2009.11.008_bib25","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/311467a0","article-title":"Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors","volume":"311","author":"Heikkila","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2009.11.008_bib26","series-title":"Guidelines For Care and Use of Animals in Scientific Research","author":"INSA","year":"2000"},{"key":"10.1016\/j.neuint.2009.11.008_bib27","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1002\/ana.21489","article-title":"Functional models of Parkinson's disease: a valuable tool in the development of novel therapies","volume":"64","author":"Jenner","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2009.11.008_bib28","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1212\/WNL.50.6_Suppl_6.S39","article-title":"Levodopa neurotoxicity: experimental studies versus clinical relevance","volume":"50","author":"Jenner","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.neuint.2009.11.008_bib29","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/j.1471-4159.1993.tb13630.x","article-title":"Absence of 6-hydroxydopamine in the rat brain after treatment with stimulants and other dopaminergic agents: a mass fragmentographic study","volume":"61","author":"Karoum","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2009.11.008_bib30","first-page":"69","article-title":"The pharmacological basis of the beneficial effects of (\u2212)deprenyl (selegiline) in Parkinson's and Alzheimer's diseases","volume":"40","author":"Knoll","year":"1993","journal-title":"J. Neural. Transm. Suppl."},{"key":"10.1016\/j.neuint.2009.11.008_bib31","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic Parkinsonian in humans due to a product of meperidine\u2013analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.neuint.2009.11.008_bib32","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/978-1-4615-4869-0_12","article-title":"Cell culture models of neuronal degeneration and neuroprotection. Implications for Parkinson's disease","volume":"446","author":"Leonardi","year":"1998","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.neuint.2009.11.008_bib33","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0300-483X(01)00541-8","article-title":"Deprenyl protects from MPTP-induced Parkinson-like syndrome and glutathione oxidation in rat striatum","volume":"170","author":"Leret","year":"2002","journal-title":"Toxicology"},{"key":"10.1016\/j.neuint.2009.11.008_bib34","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00702-002-0829-x","article-title":"Striatal formation of 6-hydroxydopamine in mice treated with pargyline, pyrogallol and methamphetamine","volume":"110","author":"Liao","year":"2003","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.neuint.2009.11.008_bib35","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.brainres.2005.09.041","article-title":"l-DOPA administration enhances 6-hydroxydopamine generation","volume":"1063","author":"Maharaj","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2009.11.008_bib36","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0361-9230(92)90035-V","article-title":"Dissociation of serotoninergic and dopaminergic components in acute effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice","volume":"28","author":"Mitra","year":"1992","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuint.2009.11.008_bib37","series-title":"Neurotoxic Factors in Parkinson's Disease and Related Disorders","first-page":"289","article-title":"Neurochemical mechanisms underlying neuroprotective actions of bromocriptine, salicylate, d- and l-deprenyl in neurodegeneration caused by MPTP","author":"Mohanakumar","year":"2000"},{"key":"10.1016\/j.neuint.2009.11.008_bib38","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.neuron.2009.01.033","article-title":"Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons","volume":"62","author":"Mosharov","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.neuint.2009.11.008_bib39","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/syn.10239","article-title":"d-Deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity","volume":"50","author":"Muralikrishnan","year":"2003","journal-title":"Synapse"},{"key":"10.1016\/j.neuint.2009.11.008_bib40","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1096\/fasebj.12.10.905","article-title":"Neuroprotection by bromocriptine against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice","volume":"12","author":"Muralikrishnan","year":"1998","journal-title":"FASEB J."},{"key":"10.1016\/j.neuint.2009.11.008_bib41","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1021\/tx990079p","article-title":"New reaction pathways of dopamine under oxidative stress conditions: nonenzymatic iron-assisted conversion to norepinephrine and the neurotoxins 6-hydroxydopamine and 6,7-dihydroxytetrahydroisoquinoline","volume":"12","author":"Napolitano","year":"1999","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.neuint.2009.11.008_bib42","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.neulet.2008.07.039","article-title":"Effects of levodopa on striatal monoamines in mice with levodopa-induced hyperactivity","volume":"443","author":"Nicholas","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuint.2009.11.008_bib43","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.neuint.2009.04.013","article-title":"Striatal dopamine level influences oxidative stress mediated neurodegeneration in 3-nitropropionic acid-induced Huntington's disease","volume":"55","author":"Pandey","year":"2009","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuint.2009.11.008_bib44","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1998"},{"key":"10.1016\/j.neuint.2009.11.008_bib45","doi-asserted-by":"crossref","first-page":"7585","DOI":"10.1016\/S0021-9258(19)57434-8","article-title":"Energy-dependent uptake of N-methyl-4-phenylpyridinium, the neurotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, by mitochondria","volume":"26","author":"Ramsay","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2009.11.008_bib46","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0014-2999(86)90011-7","article-title":"Failure to detect 6-hydroxydopamine in rat striatum after the dopamine releasing drugs dexamphetamine, methylamphetamine and MPTP","volume":"132","author":"Rollema","year":"1986","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuint.2009.11.008_bib47","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0006-8993(02)04174-4","article-title":"Non-steroidal anti-inflammatory drug sodium salicylate, but not diclofenac or celecoxib, protects against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats","volume":"966","author":"Sairam","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2009.11.008_bib48","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.neuint.2005.12.016","article-title":"l-Deprenyl protects against rotenone-induced, oxidative stress mediated dopaminergic neurodegeneration in rats","volume":"49","author":"Saravanan","year":"2006","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuint.2009.11.008_bib49","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.1468-1331.2009.02697.x","article-title":"Levodopa in the treatment of Parkinson's disease","volume":"16","author":"Schapira","year":"2009","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neuint.2009.11.008_bib50","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1474-4422(07)70327-7","article-title":"Mitochondria in the aetiology and pathogenesis of Parkinson's disease","volume":"7","author":"Schapira","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuint.2009.11.008_bib51","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1212\/WNL.0b013e3181990438","article-title":"Molecular and clinical pathways to neuroprotection of dopaminergic drugs in Parkinson disease","volume":"72","author":"Schapira","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neuint.2009.11.008_bib52","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0091-3057(84)90125-4","article-title":"Formation of 6-hydroxydopamine in caudate nucleus of the rat brain after a single large dose of methyl amphetamine","volume":"21","author":"Seiden","year":"1984","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuint.2009.11.008_bib53","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0928-4257(99)00119-9","article-title":"A behavioural study of the effect of pentadecapeptide BPC 157 in Parkinson's disease models in mice and gastric lesions induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"93","author":"Sikiric","year":"1999","journal-title":"J. Physiol. Paris"},{"key":"10.1016\/j.neuint.2009.11.008_bib54","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.pbb.2006.05.017","article-title":"Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine","volume":"84","author":"Sindhu","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuint.2009.11.008_bib55","doi-asserted-by":"crossref","first-page":"15466","DOI":"10.1016\/S0021-9258(17)36277-4","article-title":"Hydroxyl radical attack on dopamine","volume":"260","author":"Slivka","year":"1985","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2009.11.008_bib56","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1600-079X.2003.00096.x","article-title":"Melatonin protects against oxidative stress caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the mouse nigrostriatum","volume":"36","author":"Thomas","year":"2004","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.neuint.2009.11.008_bib57","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0891-5849(96)00402-9","article-title":"Hydroxyl and peroxyl radical trapping by the monoamine oxidase-B inhibitors deprenyl and MDL 72, 974A: implications for protection of biological substrates","volume":"22","author":"Thomas","year":"1997","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuint.2009.11.008_bib58","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0006-8993(99)02202-7","article-title":"In vivo hydroxyl radical generation in the striatum following systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice","volume":"852","author":"Thomas","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2009.11.008_bib59","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.pneurobio.2008.05.003","article-title":"Progress in Parkinson's disease-where do we stand?","volume":"85","author":"Toulouse","year":"2008","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuint.2009.11.008_bib60","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1021\/jm00223a008","article-title":"Potential oxidative pathways of brain catecholamines","volume":"19","author":"Tse","year":"1976","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuint.2009.11.008_bib61","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0014-2999(93)90181-G","article-title":"Apparent antioxidant effect of l-deprenyl on hydroxyl radical formation and nigral injury elicited by MPP+ in vivo","volume":"243","author":"Wu","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuint.2009.11.008_bib62","doi-asserted-by":"crossref","first-page":"S287","DOI":"10.1038\/sj.bjp.0706464","article-title":"Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness","volume":"147","author":"Youdim","year":"2006","journal-title":"Br. J. Pharmacol."}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018609003131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018609003131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T09:47:01Z","timestamp":1739440021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018609003131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0197018609003131"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2009.11.008","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}